These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19695370)

  • 1. Mechanically-induced aggregation of the monoclonal antibody cetuximab.
    Lahlou A; Blanchet B; Carvalho M; Paul M; Astier A
    Ann Pharm Fr; 2009 Sep; 67(5):340-52. PubMed ID: 19695370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface activity of a monoclonal antibody.
    Mahler HC; Senner F; Maeder K; Mueller R
    J Pharm Sci; 2009 Dec; 98(12):4525-33. PubMed ID: 19655376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and analysis of aggregates in a liquid IgG1-antibody formulation.
    Mahler HC; Müller R; Friess W; Delille A; Matheus S
    Eur J Pharm Biopharm; 2005 Apr; 59(3):407-17. PubMed ID: 15760721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
    Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
    Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shaken, not stirred: mechanical stress testing of an IgG1 antibody.
    Kiese S; Papppenberger A; Friess W; Mahler HC
    J Pharm Sci; 2008 Oct; 97(10):4347-66. PubMed ID: 18240293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equilibrium studies of protein aggregates and homogeneous nucleation in protein formulation.
    Kiese S; Pappenberger A; Friess W; Mahler HC
    J Pharm Sci; 2010 Feb; 99(2):632-44. PubMed ID: 19548315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of ipilimumab in its original vial after opening allows its use for at least 4 weeks and facilitates pooling of residues.
    Bardo-Brouard P; Vieillard V; Shekarian T; Marabelle A; Astier A; Paul M
    Eur J Cancer; 2016 May; 58():8-16. PubMed ID: 26922168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevant shaking stress conditions for antibody preformulation development.
    Eppler A; Weigandt M; Hanefeld A; Bunjes H
    Eur J Pharm Biopharm; 2010 Feb; 74(2):139-47. PubMed ID: 19922795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody.
    Awotwe-Otoo D; Agarabi C; Wu GK; Casey E; Read E; Lute S; Brorson KA; Khan MA; Shah RB
    Int J Pharm; 2012 Nov; 438(1-2):167-75. PubMed ID: 22944306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody.
    Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB
    J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation.
    Wuchner K; Büchler J; Spycher R; Dalmonte P; Volkin DB
    J Pharm Sci; 2010 Aug; 99(8):3343-61. PubMed ID: 20229596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregation.
    Kayser V; Chennamsetty N; Voynov V; Helk B; Forrer K; Trout BL
    J Pharm Sci; 2011 Jul; 100(7):2526-42. PubMed ID: 21268027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of the particle size and relative light scattering intensity of aggregates of human IgG and humanized monoclonal antibody product induced by various stress using dynamic light scattering].
    Niimi S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):55-60. PubMed ID: 22259843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term stability of diluted solutions of the monoclonal antibody rituximab.
    Paul M; Vieillard V; Jaccoulet E; Astier A
    Int J Pharm; 2012 Oct; 436(1-2):282-90. PubMed ID: 22789912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of infliximab solutions in different temperature and dilution conditions.
    Tokhadze N; Chennell P; Le Basle Y; Sautou V
    J Pharm Biomed Anal; 2018 Feb; 150():386-395. PubMed ID: 29287266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of Stress-Induced Aggregate Size Distributions and Morphological Changes of a Bi-Specific Antibody Using Orthogonal Techniques.
    Hamrang Z; Hussain M; Tingey K; Tracka M; Casas-Finet JR; Uddin S; van der Walle CF; Pluen A
    J Pharm Sci; 2015 Aug; 104(8):2473-81. PubMed ID: 26053418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Stainless Steel Exposure on the Oxidation of Polysorbate 80 in Histidine Placebo and Active Monoclonal Antibody Formulation.
    Gopalrathnam G; Sharma AN; Dodd SW; Huang L
    PDA J Pharm Sci Technol; 2018; 72(2):163-175. PubMed ID: 29343621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of polysorbate 80 quality on photostability of a monoclonal antibody.
    Singh SR; Zhang J; O'Dell C; Hsieh MC; Goldstein J; Liu J; Srivastava A
    AAPS PharmSciTech; 2012 Jun; 13(2):422-30. PubMed ID: 22362139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives.
    Wu G; Wang S; Tian Z; Zhang N; Sheng H; Dai W; Qian F
    Eur J Pharm Biopharm; 2017 Nov; 120():1-8. PubMed ID: 28754261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.